Literature DB >> 15890599

Dependence of FDG uptake on tumor microenvironment.

Andrei Pugachev1, Shutian Ruan, Sean Carlin, Steven M Larson, Jose Campa, C Clifton Ling, John L Humm.   

Abstract

PURPOSE: To investigate the factors affecting the (18)F-fluorodeoxyglucose ((18)F-FDG) uptake in tumors at a microscopic level, by correlating it with tumor hypoxia, cellular proliferation, and blood perfusion. METHODS AND MATERIALS: Nude mice bearing Dunning prostate tumors (R3327-AT) were injected with (18)F-FDG and pimonidazole, bromodeoxyuridine, and, 1 min before sacrifice, with Hoechst 33342. Selected tumor sections were imaged by phosphor plate autoradiography, while adjacent sections were used to obtain the images of the spatial distribution of Hoechst 33342, pimonidazole, and bromodeoxyuridine. The images were co-registered and analyzed on a pixel-by-pixel basis.
RESULTS: Statistical analysis of the data obtained from these tumors demonstrated that (18)F-FDG uptake was positively correlated with pimonidazole staining intensity in each data set studied. Correlation of FDG uptake with bromodeoxyuridine staining intensity was always negative. In addition, FDG uptake was always negatively correlated with the staining intensity of Hoechst 33342.
CONCLUSIONS: For the Dunning prostate tumors studied, FDG uptake was always positively correlated with hypoxia and negatively correlated with both cellular proliferation and blood flow. Therefore, for the tumor model studied, higher FDG uptake is indicative of tumor hypoxia, but neither blood flow nor cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890599     DOI: 10.1016/j.ijrobp.2005.02.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  77 in total

1.  FDG PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2009-04-01

2.  Broadening the scope of image-guided radiotherapy (IGRT).

Authors:  Carlo Greco; C Clifton Ling
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

3.  High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.

Authors:  Xiao-Feng Li; Yuanyuan Ma; Xiaorong Sun; John L Humm; C Clifton Ling; Joseph A O'Donoghue
Journal:  J Nucl Med       Date:  2010-04       Impact factor: 10.057

4.  Texture analysis of 18F-FDG PET/CT for grading thymic epithelial tumours: usefulness of combining SUV and texture parameters.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Tetsuya Shinaji; Masayuki Nakajo; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

5.  Lactic Acid Accumulation in the Tumor Microenvironment Suppresses 18F-FDG Uptake.

Authors:  Silvan Türkcan; Louise Kiru; Dominik J Naczynski; Laura S Sasportas; Guillem Pratx
Journal:  Cancer Res       Date:  2018-12-03       Impact factor: 12.701

6.  A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.

Authors:  Masatoyo Nakajo; Yoriko Kajiya; Atsushi Tani; Megumi Jinguji; Masayuki Nakajo; Masaki Kitazono; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-03       Impact factor: 9.236

Review 7.  Hypoxia in microscopic tumors.

Authors:  Xiao-Feng Li; Joseph A O'Donoghue
Journal:  Cancer Lett       Date:  2008-04-01       Impact factor: 8.679

8.  Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.

Authors:  Xiao-Feng Li; Tao Huang; Huijie Jiang; Xuemei Wang; Baozhong Shen; Xiangcheng Wang; Chin K Ng; Gregory C Postel; A Cahid Civelek
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 9.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

10.  FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo.

Authors:  D Cejka; C Kuntner; M Preusser; M Fritzer-Szekeres; B J Fueger; S Strommer; J Werzowa; T Fuereder; T Wanek; M Zsebedics; M Mueller; O Langer; V Wacheck
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.